Netherlands· NL-4af3d4503492
Livocab 0,5 mg/ml oogdruppels, suspensie
A levocabastine product containing levocabastinehydrochloride, registered in Netherlands by Kenvue Netherlands B.V.. The same ATC class is registered in 9 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Levocabastine is registered in 9 of 19 countries.
Countries holding a registration under ATC S01GX02 (levocabastine), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 6 of them publish a price we can compare per daily dose
Levocabastine · ATC S01GX02
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- LEVOCABASTINEHYDROCHLORIDE
- Manufacturer
- Kenvue Netherlands B.V.
- Country
- Netherlands (NL)
- ATC code
- S01GX02
- ATC class
- Levocabastine
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id13968
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Levocabastine in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumLivostin 0.5 mg/mlPI Pharma
- FinlandLivostinParanova Oy
- CzechiaLIVOSTINMcNeil Healthcare (Ireland) Limited, Dublin
- IcelandLivostinMcNeil Sweden AB
- NorwayLivostinMcNeil Sweden AB
- SwedenLivostin 0,5 mg/ml Ögondroppar, suspensionMcNeil Sweden AB
- GermanyLevocabastinDermapharm Ag
- United KingdomLivostin 0.05% nasal sprayNovartis Pharmaceuticals UK Ltd
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Levocamed, Livostin
- Belgium · Livostin, Nasasinuspray Anti-Allergie
- Czechia · Livostin
- Germany · Levocabastin, Levocamed
- Denmark · Benaliv
- Spain · Bilina, Reactine
- Finland · Livostin
- France · Allergiflash, Levofree
- Greece · Livostin
- Iceland · Livostin
- Italy · Levoreact, Levoreact Oftalmico
- Luxembourg · Livostin, Nasasinuspray Anti-Allergie
- Norway · Livostin
- Sweden · Livostin
- Slovakia · Livostin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9bae23b5-1507-4ef9-ae59-90828c0599d4 GET /v1/drugs/9bae23b5-1507-4ef9-ae59-90828c0599d4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oogdruppels, suspensie",
"route": "Oculair gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h13968_smpc.pdf",
"strength": null,
"atc_label": "Levocabastine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg13968",
"excipients": [
"BENZALKONIUMCHLORIDE",
"DINATRIUMEDETAAT 2-WATER",
"DINATRIUMWATERSTOFFOSFAAT 0-WATER (E 339)",
"HYPROMELLOSE (E 464)",
"NATRIUMDIWATERSTOFFOSFAAT 1-WATER (E 339)",
"POLYSORBAAT 80 (E 433)",
"PROPYLEENGLYCOL (E 1520)",
"WATER VOOR INJECTIE"
],
"substances": [
"LEVOCABASTINEHYDROCHLORIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h13968.pdf",
"authorised_at": "1991/10/04",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "13968",
"additional_monitoring": "N"
}See everything about levocabastine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.